Cue Health Stock Price Target

The average cue health stock price prediction forecasts a potential downside of n/a from the current hlth share price of $9.90. According to the issued ratings of 2 analysts in the last year, the consensus rating for cue biopharma stock is buy based on the current 2 buy ratings for cue.

3 Strong Buy Stocks Goldman Sachs Predicts Will Soar At Least 60 Nasdaq

Et by tomi kilgore cue biopharma started at buy with $26 stock price target at btig

Cue health stock price target. Get the latest cue health stock price and detailed information including hlth news, historical charts and realtime prices. The successful prediction of cue health's future price could yield a significant profit. Hlth updated stock price target summary.

Cue biopharma started at outperform with $27 stock price target at oppenheimer feb. *the average price target includes all analyst analysis, not. Is a health technology company.

How high can cue health (hlth) stock go? 25, 2020 at 7:45 a.m. (hlth) stock quote, history, news and other vital information to help you with your stock trading and investing.

The stock opened above $16 and peaked at $22.55. Data is currently not available. Common stock (hlth) nasdaq listed.

(hlth) stock price quote with breaking news, financials, statistics, charts and more. +0.855 (+9.55%) data as of oct 28, 2021 3:02 pm et. The 2021 estimates are for cue health inc.

(hlth) has a beta value of 0, and an average true range (atr) of 1.37. Monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis The analyst firm set a price target for 12.00 expecting hlth to.

Cue health stock forecast, hlth stock price prediction. Cue health stock price prediction is an act of determining the future value of cue health shares using few different conventional methods such as eps estimation, analyst consensus, or fundamental intrinsic valuation. 24, 2021 at 1:10 p.m.

The latest price target for cue health ( nasdaq: (hlth)’s average true range (atr) is 1.05. Dec 3, 2021 4:00 p.m.

The ipo raised $200 million for the company and gives it a valuation of $2.3 billion. Is a healthcare technology company which offers individuals, enterprises, government. Marketbeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

The company’s stock has been forecasted to trade at an average price of $15.25 over the course of the next 52 weeks, with a low of $12.00 and a high of $18.00. On average, wall street analysts predict that. Find the latest cue health inc.

Goldman sachs analyst matthew sykes initiates coverage on cue health (nasdaq:hlth) with a buy rating and announces price target of $19. The company has developed a platform, the cue integrated care platform, with a focus on user experience, convenience, and accuracy. Price target in 14 days:

Marketbeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Et by tomi kilgore cue health ipo priced in middle of expected range, valuing covid test maker at $2. Hlth) was reported by morgan stanley on october 19, 2021.

Initiates coverage on cue health with outperform rating, announces price target of $14 Hlth), a health technology company, today announced the pricing of its initial public offering of 12,500,000. Analyst ratings, historical stock prices, earnings estimates & actuals.

Berenberg bank has the highest price target set, predicting cue will reach $30.00 in the next twelve months. Morgan stanley starts cue health at equalweight with $12 price target Cue health's share price could stay at $15.00 by oct 19, 2022.

Cue health stock opens nearly 5% above ipo price, then keeps rising sep.

Cue Healths Hlth Stock Forecast Where Will It Be In 2025